Merck halts shipments of key cancer drug to Greece
Xeni Jardin at 8:23 am Sat, Nov 3, 2012
The German pharmaceuticals maker
Merck will no longer deliver the cancer drug Erbitux to Greek hospitals, according to a statement from the company today. The drug
also known as cetuximab is often used for patients with head and neck cancers. The move to halt distribution is a sign of a worsening economic and budget crisis, and its impact on critical services including care for cancer patients.
(thanks, Gerrit)